Fund Holdings — Sands Capital Alternatives, LLC

Total Portfolio Value:
$359.46M
Total Bought:
$23.04M
Total Sold:
$72.27M
Net Transaction:
-$49.24M
Notable People:
Sands Capital Management, Lp, Erin Elizabeth Soule
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Nu Holdings Ltd.CL A(NU)9,152,5489,155,661+3,113$66.36M$76.27M21.22%+$9.91M
DoorDash, Inc.CL A(DASH)603,512603,288-224$47.96M$59.66M16.60%+$11.70M
UiPath, Inc.CL A(PATH)3,066,5692,303,452-763,117$52.47M$57.22M15.92%+$4.75M
Rayzebio, Inc.1,195,589778,922-416,667$26.54M$48.43M13.47%+$21.88M
Snowflake Inc.CL A(SNOW)215,799215,843+44$32.97M$42.95M11.95%+$9.99M
10x Genomics, Inc.CL A(TXG)481,770481,7700$19.87M$26.96M7.50%+$7.09M
Acumen Pharmaceuticals, Inc.(ABOS)3,417,0753,417,0750$14.18M$13.12M3.65%-$1.06M
Klaviyo, Inc.COM SER A(KVYO)469,431471,260+1,829$16.20M$13.09M3.64%-$3.10M
Acrivon Therapeutics Inc1,652,6051,652,6050$15.80M$8.13M2.26%-$7.67M
Tarsus Pharmaceuticals, Inc.(TARS)260,000260,0000$4.62M$5.26M1.46%+$644.8K
908 Devices Inc.(MASS)237,258237,2580$1.58M$2.66M0.74%+$1.08M
Spruce Biosciences Inc787,007787,0070$1.78M$2.31M0.64%+$527.3K
Taysha Gene Therapies, Inc.(TSHA)724,873724,8730$2.29M$1.28M0.36%-$1.01M
Candel Therapeutics, Inc.(CADL)811,737811,7370$746.8K$1.19M0.33%+$446.5K
Absci Corporation57,80457,8040$76.3K$242.8K0.07%+$166.5K
Coupang, Inc.CL A(CPNG)8,43810,451+2,013$143.4K$169.2K0.05%+$25.8K
Toast, Inc.CL A(TOST)7,1217,865+744$133.4K$143.6K0.04%+$10.2K
Datadog, Inc.CL A(DDOG)1,3661,015-351$124.4K$123.2K0.03%-$1.2K
Samsara Inc.CL A(IOT)934,7373,570-931,167$23.56M$119.2K0.03%-$23.45M
CrowdStrike Holdings, Inc.CL A(CRWD)865344-521$144.8K$87.8K0.02%-$57.0K
GitLab Inc.CL A(GTLB)6586580$29.8K$41.4K0.01%+$11.7K
OLINK HLDG ABSPONSORED ADS705,5140-705,514$10.41M$0—-$10.41M
CONFLUENT INCCLASS A COM1,1610-1,161$34.4K$0—-$34.4K
Page 1 of 1